Clinical trial

REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction…

NCT00271154 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Completed

Key facts

NCT number NCT00271154
Title REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)
Official title REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)
Lead sponsor Medtronic Cardiac Rhythm and Heart Failure, Industry
Status Completed
Study type Interventional
Conditions Heart Failure
Intervention type Device
Interventions Cardiac Resynchronization Therapy (CRT) Device or Implantable Cardioverter Defibrillator (ICD) with CRT
Enrollment 684
Start date Sep 1, 2004
Primary completion Oct 1, 2007
Completion Nov 1, 2011
First posted Dec 30, 2005
Last update posted Jan 30, 2012
Countries Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Hungary, Ireland, Italy, Norway, Spain and 3 more

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies